tiprankstipranks
Trending News
More News >
Edwards Lifesciences (EW)
NYSE:EW
Advertisement

Edwards Lifesciences (EW) Stock Statistics & Valuation Metrics

Compare
1,880 Followers

Total Valuation

Edwards Lifesciences has a market cap or net worth of $44.87B. The enterprise value is $42.34B.
Market Cap$44.87B
Enterprise Value$42.34B

Share Statistics

Edwards Lifesciences has 586,600,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding586,600,000
Owned by Insiders0.23%
Owned by Institutions1.07%

Financial Efficiency

Edwards Lifesciences’s return on equity (ROE) is 0.42 and return on invested capital (ROIC) is 10.72%.
Return on Equity (ROE)0.42
Return on Assets (ROA)0.32
Return on Invested Capital (ROIC)10.72%
Return on Capital Employed (ROCE)0.12
Revenue Per Employee344.27K
Profits Per Employee263.91K
Employee Count15,800
Asset Turnover0.42
Inventory Turnover1.03

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio51.1
PS Ratio0.00
PB Ratio4.47
Price to Fair Value4.43
Price to FCF154.15
Price to Operating Cash Flow82.45
PEG Ratio24.88

Income Statement

In the last 12 months, Edwards Lifesciences had revenue of 5.44B and earned 4.17B in profits. Earnings per share was 6.98.
Revenue5.44B
Gross Profit4.32B
Operating Income1.38B
Pretax Income1.55B
Net Income4.17B
EBITDA1.72B
Earnings Per Share (EPS)6.98

Cash Flow

In the last 12 months, operating cash flow was 876.20M and capital expenditures -223.10M, giving a free cash flow of 653.10M billion.
Operating Cash Flow876.20M
Free Cash Flow653.10M
Free Cash Flow per Share1.11

Dividends & Yields

Edwards Lifesciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.89
52-Week Price Change-13.07%
50-Day Moving Average76.46
200-Day Moving Average72.33
Relative Strength Index (RSI)48.92
Average Volume (3m)3.60M

Important Dates

Edwards Lifesciences upcoming earnings date is Jul 24, 2025, After Close (Confirmed).
Last Earnings DateApr 23, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend Date

Financial Position

Edwards Lifesciences as a current ratio of 4.18, with Debt / Equity ratio of 7.00%
Current Ratio4.18
Quick Ratio3.45
Debt to Market Cap0.01
Net Debt to EBITDA-1.36
Interest Coverage Ratio69.63

Taxes

In the past 12 months, Edwards Lifesciences has paid 152.10M in taxes.
Income Tax152.10M
Effective Tax Rate0.10

Enterprise Valuation

Edwards Lifesciences EV to EBITDA ratio is 24.32, with an EV/FCF ratio of 144.54.
EV to Sales7.70
EV to EBITDA24.32
EV to Free Cash Flow144.54
EV to Operating Cash Flow77.27

Balance Sheet

Edwards Lifesciences has $3.90B in cash and marketable securities with $699.40M in debt, giving a net cash position of -$3.20B billion.
Cash & Marketable Securities$3.90B
Total Debt$699.40M
Net Cash-$3.20B
Net Cash Per Share-$5.45
Tangible Book Value Per Share$11.89

Margins

Gross margin is 79.18%, with operating margin of 25.35%, and net profit margin of 76.75%.
Gross Margin79.18%
Operating Margin25.35%
Pretax Margin28.46%
Net Profit Margin76.75%
EBITDA Margin31.68%
EBIT Margin28.82%

Analyst Forecast

The average price target for Edwards Lifesciences is $83.87, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$83.87
Price Target Upside9.65% Upside
Analyst ConsensusModerate Buy
Analyst Count19
Revenue Growth Forecast-9.84%
EPS Growth Forecast-35.77%

Scores

Smart Score6
AI Score71
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis